Revenue
2018
2019
2020
2021
2022
2023
2024
2025
Pediatrix Medical Group, Inc. (MD)
Price—Loading quote
Net income
2018
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2018
2019
2020
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.91B | $2.01B | $1.99B | $1.97B | $1.91B | $1.73B | $1.78B | $1.72B | $3.25B | $3.18B | — | — | — | — | — | — | — | — |
| Operating expenses | $1.71B | $2.08B | $1.99B | $1.80B | $1.71B | $1.64B | $1.61B | $1.47B | $2.80B | $2.61B | $2.22B | $1.93B | $1.70B | $1.43B | $1.23B | $1.09B | $999.3M | $826.2M |
| Operating income | $208.8M | −$68.7M | $7.3M | $172.7M | $202.9M | $98.1M | $171.8M | $248.4M | $454.9M | $571.7M | $557.9M | $513.0M | $452.1M | $389.5M | $355.4M | $312.9M | $288.9M | $242.0M |
| EBITDAderived | $230.6M | −$36.5M | $43.5M | $208.3M | $235.1M | $126.6M | $197.7M | $272.7M | $533.7M | $661.0M | $622.1M | $559.0M | $492.1M | $420.3M | $380.7M | $334.9M | $305.4M | $255.2M |
| Net income | $165.4M | −$99.1M | −$60.4M | $66.3M | $131.0M | −$796.5M | −$1.50B | $268.6M | $320.4M | $324.9M | $336.3M | $317.3M | $280.5M | $240.9M | $218.0M | $202.7M | $175.8M | $169.2M |
| Basic EPSper diluted share | $1.97 | -$1.19 | -$0.73 | $0.79 | $1.54 | -$9.55 | -$17.94 | $2.95 | $3.47 | $3.52 | $3.61 | $3.22 | $2.83 | $2.47 | $2.28 | $4.35 | $3.86 | $3.67 |
| Diluted EPSper diluted share | $1.94 | -$1.19 | -$0.73 | $0.79 | $1.53 | -$9.55 | -$17.83 | $2.93 | $3.45 | $3.49 | $3.58 | $3.18 | $2.78 | $2.42 | $2.23 | $4.26 | $3.78 | $3.59 |
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| May 13, 2026Form 4 | Weis Shirley ADirector | SellCommon Stock · indirect | 36.0K | $23.75 | $855.7K | 0 |
| Dec 15, 2025Form 4 | ORDAN MARK SChief Executive Officer | SellCommon Stock | 23.0K | $22.41 | $515.4K | 302.8K |
| Nov 17, 2025Form 4 | Rucker Michael A.Director | SellCommon Stock | 10.5K | $23.00 | $241.0K | 59.1K |
| Nov 6, 2025Form 4 | Linynsky Laura ADirector | SellCommon Stock | 10.0K | $21.65 | $216.5K | 32.2K |
| Nov 13, 2024Form 4 | ORDAN MARK SDirector | SellCommon Stock | 27.6K | $15.35 | $423.7K | 138.7K |